Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CTSG | P08311 | 1/20 | 0.32 |
| ▸ | CTRC | Q99895 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1830394 | 0.77 | L3MBTL1 (0.38) | F2ELANECTSGCTRC | |
| SCHEMBL7246666 | 0.75 | ALOX5 (0.35) | F2ELANECTSGCTRC | |
| SCHEMBL13574982 | 0.72 | PIK3CD (0.31) | F2ELANECTSGCTRC | |
| SCHEMBL4032366 | 0.72 | TP53 (0.33) | F2ELANECTSGCTRC | |
| SCHEMBL8629144 | 0.72 | PIK3CD (0.31) | F2ELANECTSGCTRC | |
| SCHEMBL9848987 | 0.69 | — | — | |
| SCHEMBL9848985 | 0.68 | — | — | |
| SCHEMBL8671581 | 0.64 | L3MBTL1 (0.34) | F2ELANECTSGCTRC | |
| SCHEMBL23607701 | 0.63 | GAA (0.33) | — | |
| SCHEMBL24658347 | 0.62 | P2RX7 (0.39) | F2ELANECTSGCTRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11390607-B2 | Process to prepare propylene amines and propylene amine derivatives | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-07-19 | — | — | US | disclosed |
| US-20200361910-A1 | PROCESS TO PREPARE PROPYLENE AMINES AND PROPYLENE AMINE DERIVATIVES | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-11-19 | — | — | US | disclosed |
| EP-3665168-A1 | PROCESS TO PREPARE PROPYLENE AMINES AND PROPYLENE AMINE DERIVATIVES | Nouryon Chemicals International B.V. (NL) | 2020-06-17 | — | — | EP | disclosed |
| CN-110997659-A | Process for preparing propyleneamine and propyleneamine derivatives | 诺力昂化学品国际有限公司 | 2020-04-10 | — | — | CN | disclosed |
| WO-2019030197-A1 | PROCESS TO PREPARE PROPYLENE AMINES AND PROPYLENE AMINE DERIVATIVES | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2019-02-14 | — | — | WO | disclosed |
| US-6630599-B1 | Blocked derivatives of m- or p- isopropenyl- alpha , alpha -dimethylbenzyl isocyanates, comprising reacting a meta- or a para-isopropenyl-alpha, alpha-dimethylbenzyl carbamate ester with hydroxy functional blocking group, such as | CYTEC TECHNOLOGY CORP. | 2003-10-07 | — | — | US | disclosed |
| US-6307058-B1 | USEFUL IN PAPER AND TEXTILE APPLICATIONS AND IN IMPROVING WET ADHESION PROPERTIES OF LATEX PAINTS. | CYTEC TECHNOLOGY CORP. | 2001-10-23 | — | — | US | disclosed |
| US-6166220-A | Ethylenically unsaturated imidazidolidinone monomers | CYTEC TECHNOLOGY CORP. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-0928820-A2 | Wet adhesion promoter | CYTEC TECHNOLOGY CORP. (US) | 1999-07-14 | — | — | EP | disclosed |
| EP-0925283-A1 | NOVEL POLYMERIZABLE ACYL IMIDAZOLIDINONE MONOMERS | Cytec Technology Corp. (US) | 1999-06-30 | — | — | EP | disclosed |
| EP-0923559-A1 | POLYMERIZABLE UREA/UREIDO FUNCTIONAL MONOMERS | Cytec Technology Corp. (US) | 1999-06-23 | — | — | EP | disclosed |
| WO-1997049686-A1 | NOVEL POLYMERIZABLE ACYL IMIDAZOLIDINONE MONOMERS | CYTEC TECHNOLOGY CORP. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997049685-A1 | POLYMERIZABLE UREA/UREIDO FUNCTIONAL MONOMERS | CYTEC TECHNOLOGY CORP. (US) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200361910-A1 | PROCESS TO PREPARE PROPYLENE AMINES AND PROPYLENE AMINE DERIVATIVES | HRH3, HRH4, HRH1 | F2 1223/4885ELANE 577/4885CTSG 4588/4885 |
| US-11390607-B2 | Process to prepare propylene amines and propylene amine derivatives | HRH3, HRH4, HRH1 | F2 1350/4885ELANE 555/4885CTSG 4557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.